MD4520C1 - N-(4-butoxifenil)-2-(piridin-2-ilmetiliden)hidrazincarbotioamida în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar - Google Patents
N-(4-butoxifenil)-2-(piridin-2-ilmetiliden)hidrazincarbotioamida în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamarInfo
- Publication number
- MD4520C1 MD4520C1 MDA20160141A MD20160141A MD4520C1 MD 4520 C1 MD4520 C1 MD 4520C1 MD A20160141 A MDA20160141 A MD A20160141A MD 20160141 A MD20160141 A MD 20160141A MD 4520 C1 MD4520 C1 MD 4520C1
- Authority
- MD
- Moldova
- Prior art keywords
- breast cancer
- cancer cells
- ylmethylidene
- hydrazinecarbothioamide
- butoxyphenyl
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 4
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 4
- UUOPJNVEEGYJRI-UHFFFAOYSA-N 1-(4-butoxyphenyl)-3-(pyridin-2-ylmethylideneamino)thiourea Chemical compound C(CCC)OC1=CC=C(C=C1)NC(=S)NN=CC1=NC=CC=C1 UUOPJNVEEGYJRI-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003966 growth inhibitor Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 239000002254 cytotoxic agent Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 150000002894 organic compounds Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003583 thiosemicarbazides Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Invenţia se referă la chimie şi medicină, şi anume la un compus organic biologic activ din clasa tiosemicarbazidelor şi poate găsi implementare în medicină ca preparat citostatic pentru profilaxia şi tratarea cancerului mamar.Esenţa invenţiei constă în utilizarea compusului nou N-(4-butoxifenil)-2-(piridin-2-ilmetiliden)hidrazincarbotioamidei cu formula:în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar, care la concentraţia de 10-7 mol/L inhibă creşterea şi multiplicarea a 44,2% de celule T-47D ale cancerului mamar.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20160141A MD4520C1 (ro) | 2016-12-16 | 2016-12-16 | N-(4-butoxifenil)-2-(piridin-2-ilmetiliden)hidrazincarbotioamida în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20160141A MD4520C1 (ro) | 2016-12-16 | 2016-12-16 | N-(4-butoxifenil)-2-(piridin-2-ilmetiliden)hidrazincarbotioamida în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD4520B1 MD4520B1 (ro) | 2017-10-31 |
| MD4520C1 true MD4520C1 (ro) | 2018-05-31 |
Family
ID=60243236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20160141A MD4520C1 (ro) | 2016-12-16 | 2016-12-16 | N-(4-butoxifenil)-2-(piridin-2-ilmetiliden)hidrazincarbotioamida în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD4520C1 (ro) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5281715A (en) * | 1992-05-13 | 1994-01-25 | Yale University | 2-formylpyridine thiosemicarbazone compounds |
| EP2240175B1 (en) * | 2008-02-11 | 2013-01-02 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Compounds with mdr1-inverse activity |
| MD3995C2 (ro) * | 2009-05-11 | 2010-07-31 | Государственный Университет Молд0 | Utilizare a di(µ-Ofenoxi)-di{[2-(4-aminobenzensulfamido)-5-etil-1,3,4-tiadiazol]-3,5-dibromosalicilidentiosemicarbazonato(-1)-cupru} în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar |
| WO2012033601A1 (en) * | 2010-08-20 | 2012-03-15 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Thiosemicarbazones with mdr1 - inverse activity |
| MD4132C1 (ro) * | 2010-12-13 | 2012-05-31 | Государственный Университет Молд0 | Di(µ-S)-bis{cloro-[fenil(piridin-2-il)metanon-tiosemicarbazonato(1-)]cupru} care manifestă proprietatea de inhibare a proliferării celulelor T-47D ale cancerului mamar |
| MD4215C1 (ro) * | 2012-07-09 | 2013-11-30 | Государственный Университет Молд0 | Inhibitor al leucemiei mieloide umane în bază de N-(4-(5-(piridin-2-il)-4,5-dihidro-1H-pirazol-3-il)fenil)-2-(piridin-2-ilmetilen)-hidrazincarbotioamidă |
| MD4349C1 (ro) * | 2014-06-23 | 2015-12-31 | Государственный Университет Молд0 | Compusul N-(3-metoxifenil)-2-(piridin-2-ilmetilen)-hidrazincarbotioamidă - inhibitor al proliferării celulelor MeW-164 ale melanomului uman |
| MD4407C1 (ro) * | 2015-04-29 | 2016-10-31 | Государственный Университет Молд0 | Inhibitor al celulelor HL-60 ale leucemiei umane mieloide în baza hidratului clorurii de bis[N-(prop-2-en-1-il)-2-(piridin-2-ilmetiliden)-hidrazincarbotioamid]-nichel(II) |
-
2016
- 2016-12-16 MD MDA20160141A patent/MD4520C1/ro not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD4520B1 (ro) | 2017-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201992806A1 (ru) | Ингибирование роста кристалла рофлумиласта | |
| EA201891049A1 (ru) | Изоиндолиновые, азаизоиндолиновые, дигидроинденоновые и дигидроазаинденоновые ингибиторы mnk1 и mnk2 | |
| MD3500564T2 (ro) | Inhibitori ai diacilglicerol aciltransferazei 2 | |
| TR201901312T4 (tr) | Mcl-1 proteinini inhibe eden tetrahidronaftalen türevleri. | |
| MX2024006689A (es) | Sales monoacidas de 6-aminoisoquinolinas y usos de las mismas. | |
| EA201500394A1 (ru) | Ингибиторы деметилаз гистонов | |
| PH12015502365A1 (en) | Bace1 inhibitors | |
| CY1122077T1 (el) | Νεα δακτυλιωμενα φαινοξυακεταμιδια | |
| RU2018135973A (ru) | Фармацевтическая комбинация, содержащая метроформин и дигидрокверценин, и ее применение для лечения рака | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| EA201790726A1 (ru) | Фармацевтическая композиция для лечения язвенного колита | |
| PE20210859A1 (es) | Inhibidores de triazol glicolato oxidasa | |
| PH12015501945B1 (en) | Formulations of organic compounds | |
| EA201891319A1 (ru) | Соединения алкилдигидрохинолинсульфонамида | |
| MX2020014262A (es) | Composicion farmaceutica que comprende un agente basico poco soluble. | |
| MX2017010157A (es) | Compuestos con actividad anti-tumoral. | |
| MX2017012188A (es) | Inhibidores de beta-secretasa 1 (bace1). | |
| MD4520C1 (ro) | N-(4-butoxifenil)-2-(piridin-2-ilmetiliden)hidrazincarbotioamida în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar | |
| MX2016006906A (es) | 5-aril-1-imino-1-oxo-[1,2,4]tiadiazinas. | |
| MX2024005304A (es) | Derivado del acido fenilpropionico sustituido y uso del mismo. | |
| MD4402B1 (ro) | Metil-N'-[(2-hidroxinaftalen-1-il)metiliden]-N-prop-2-en-1-ilhidrazonotioat, care manifestă activitate antimicotică faţă de Candida albicans | |
| MX2016016061A (es) | 2,2,2-trifluoroetil-tiadiazinas. | |
| EA201992303A1 (ru) | СОЕДИНЕНИЯ, КОТОРЫЕ ИНГИБИРУЮТ БЕЛОК Mcl-1 | |
| PL413779A1 (pl) | Zastosowanie medyczne 4-cykloheksylo-1-(4-nitrofenylo)-karbonylotiosemikarbazydu oraz kompozycja farmaceutyczna | |
| EA201991630A1 (ru) | Соединение хиназолина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |